Skip to content

LSD research published in 2017

44 studies whose primary subject is LSD were published in 2017, up from 39 in 2016. Newest first. Back to the LSD overview

Studies

A Brief Review of Chemistry and Pharmacology of Lysergic Acid Diethylamide

December 30, 2017 S. Jadhav, Trupti Ghatage, A. M. Thanekar

Lysergic acid diethylamide (LSD), is a classical hallucinogen, discovered accidentally in the middle century. It is a psychedelic drug used to treat drug abuse as it shows limited efficacy, leaving severe and persistent effects in treated patients. Preliminary studies in animals and clinical trials suggest that lysergic acid diethylamide may have anti-depressive, anxiolytic, hallucinogenic and...

Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD.

Scientific Reports December 15, 2017 Selen Atasoy, Leor Roseman, Mendel Kaelen et al. 225 citations

Recent studies have started to elucidate the effects of lysergic acid diethylamide (LSD) on the human brain but the underlying dynamics are not yet fully understood. Here we used 'connectome-harmonic decomposition', a novel method to investigate the dynamical changes in brain states. We found that LSD alters the energy and the power of individual harmonic brain states in a frequency-selective...

The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review

Frontiers in Psychiatry November 20, 2017 Laura Orsolini, Gabriele Duccio Papanti, Domenico de Berardis et al. 99 citations

Hallucinogen-persisting perception disorder (HPPD) is a syndrome characterized by prolonged or reoccurring perceptual symptoms, reminiscent of acute hallucinogen effects. HPPD was associated with a broader range of LSD (lysergic acid diethylamide)-like substances, cannabis, methylenedioxymethamphetamine (MDMA), psilocybin, mescaline, and psychostimulants. The recent emergence of novel...

LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm.

Neuropharmacology November 20, 2017 Christopher Timmermann, Meg J. Spriggs, Mendel Kaelen et al. 83 citations

Under the predictive coding framework, perceptual learning and inference are dependent on the interaction between top-down predictions and bottom-up sensory signals both between and within regions in a network. However, how such feedback and feedforward connections are modulated in the state induced by lysergic acid diethylamide (LSD) is poorly understood. In this study, an auditory oddball...

DOI: 10.1016/j.neuropharm.2017.10.039 (opens in new tab) LSD LSD Neuroscience brain Neural adaptation Brain network dynamics +2

Anxiety and depression symptoms in Brazilian sexual minority ecstasy and LSD users

Trends in Psychiatry and Psychotherapy November 11, 2017 Lysa Remy, Juliana Nichterwitz Scherer, Luciano Santos Pinto Guimarães et al. 12 citations

Abstract Background This study examined drug use patterns and psychiatric symptoms of anxiety and depression among young Brazilian sexual minority ecstasy and LSD users and compared findings with those reported for their heterosexual peers. Method This cross-sectional study employed targeted sampling and ethnographic mapping approaches via face-to-face interviews conducted at bars and...

LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation

Frontiers in Pharmacology November 8, 2017 Rainer Kraehenmann, Dan Pokorný, Helena Aicher et al. 115 citations

Rationale: Stimulation of serotonin 2A (5-HT2A) receptors by lysergic acid diethylamide (LSD) and related compounds such as psilocybin has previously been shown to increase primary process thinking – an ontologically and evolutionary early, implicit, associative, and automatic mode of thinking which is typically occurring during altered states of consciousness such as dreaming. However, it is...

Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey

Scientific Reports November 3, 2017 Will Lawn, Jaime E. C. Hallak, José Alexandre S. Crippa et al. 78 citations

Abstract Ayahuasca is a natural psychedelic brew, which contains dimethyltryptamine (DMT). Its potential as a psychiatric medicine has recently been demonstrated and its non-medical use around the world appears to be growing. We aimed to investigate well-being and problematic alcohol use in ayahuasca users, and ayahuasca’s subjective effects. An online, self-selecting, global survey examining...

Acute LSD effects on response inhibition neural networks

Psychological Medicine October 2, 2017 André Schmidt, Felix Müller, Claudia Lenz et al. 62 citations

Abstract Background Recent evidence shows that the serotonin 2A receptor (5-hydroxytryptamine2A receptor, 5-HT 2A R) is critically involved in the formation of visual hallucinations and cognitive impairments in lysergic acid diethylamide (LSD)-induced states and neuropsychiatric diseases. However, the interaction between 5-HT 2A R activation, cognitive impairments and visual hallucinations is...

DOI: 10.1017/s0033291717002914 (opens in new tab) Lysergic acid diethylamide Visual hallucination Parahippocampal gyrus Cingulate cortex +6

Psychedelic Drugs in Biomedicine

TIPS - Trends in Pharmacological Sciences September 22, 2017 Evan J. Kyzar, Charles D. Nichols, Raul R. Gainetdinov et al. 155 citations

Psychedelic drugs, such as lysergic acid diethylamide (LSD), mescaline, and psilocybin, exert profound effects on brain and behavior. After decades of difficulties in studying these compounds, psychedelics are again being tested as potential treatments for intractable biomedical disorders. Preclinical research of psychedelics complements human neuroimaging studies and pilot clinical trials,...

Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations

Acta Psychiatrica Scandinavica September 21, 2017 Felix Müller, Claudia Lenz, Patrick C. Dolder et al. 149 citations

Objective It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thus of interest to test the effects of these drugs on this system. Method 100 μg LSD was...

Let’s Go Out For A Day Trip? Perspectives of Psychedelics (Ab)Users on the Safety of Acid (LSD) Tripping in Public Places

Global Journal of Health Science September 18, 2017 Ahmed Al-Imam

BACKGROUND: Novel psychoactive substances (NPS) represent a unique phenomenon of the 21st century. These substances are of critical consequences on public health and national economies. Hallucinogens, also known as psychedelics and entheogens, represent one category of NPS. Numerous private groups do exist on the online drug fora and the online social platforms including Facebook. Psychedelic...

Long-lasting subjective effects of LSD in normal subjects

Psychopharmacology September 16, 2017 Yasmin Schmid, Matthias E. Liechti 234 citations

RATIONALE: Lysergic acid diethylamide (LSD) and other serotonergic hallucinogens can induce profound alterations of consciousness and mystical-type experiences, with reportedly long-lasting effects on subjective well-being and personality. METHODS: We investigated the lasting effects of a single dose of LSD (200 μg) that was administered in a laboratory setting in 16 healthy participants. The...

Serotonin 2A Receptor Signaling Underlies LSD-induced Alteration of the Neural Response to Dynamic Changes in Music

Cerebral Cortex September 12, 2017 Frederick S. Barrett, Katrin H. Preller, Marcus Herdener et al. 52 citations

Abstract Classic psychedelic drugs (serotonin 2A, or 5HT2A, receptor agonists) have notable effects on music listening. In the current report, blood oxygen level-dependent (BOLD) signal was collected during music listening in 25 healthy adults after administration of placebo, lysergic acid diethylamide (LSD), and LSD pretreated with the 5HT2A antagonist ketanserin, to investigate the role of...

Psychoactive substances as a last resort—a qualitative study of self-treatment of migraine and cluster headaches

Harm Reduction Journal September 4, 2017 Martin Andersson, Mari Persson, Anette Kjellgren 93 citations

BACKGROUND: Treatment resistant cluster headache and migraine patients are exploring alternative treatments online. The aim of this study was to improve comprehension regarding the use of non-established or alternative pharmacological treatments used by sufferers of cluster headaches and migraines. METHODS: A qualitative thematic analysis of the users' own accounts presented in online forum...

Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use.

American Journal on Addictions September 2017 Shaul Lev-Ran, Daniel Feingold, Craig Goodman et al.

Exploring differences in visual disturbances and triggers between Hallucinogen-Persisting-Perceptual-Disorder (HPPD) Type I ("positive/benign") and II ("negative/distressing"). Forty individuals with HPPD and prior LSD use completed clinical questionnaires. The most common type of visual disturbances among individuals with HPPD I and II was slow movement of still objects and trailing phenomena,...

MDA, MDMA, and other “mescaline‐like” substances in the US military's search for a truth drug (1940s to 1960s)

Drug Testing and Analysis August 29, 2017 Torsten Passie, Udo Benzenhöfer 43 citations

Abstract This article describes the context in which 3,4‐methylenedioxyamphetamine (MDA), 3,4‐methylenedioxymethamphetamine (MDMA) and other mescaline‐like compounds were explored as hallucinogens for military and intelligence purposes from the 1940s to the 1960s. Germans first tested mescaline as a “truth drug” in a military context. In the 1940s, the United States military started testing...

A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment

Journal of Psychedelic Studies August 29, 2017 Eduardo Ekman Schenberg, Maria Angélica de Castro Comis, João Felipe Morel Alexandre et al. 39 citations

Objective This report documents the phenomenology of the subjective experiences of 22 patients with substance-related disorders who were involved in a treatment combining cognitive–behavioral therapy and hospital sessions with ibogaine in Brazil. Methods Participants underwent a one-to-one semi-structured interview exploring the subjective effects of ibogaine. We employed interpretative...

Effect of LSD-25 (lysergic acid — diethyl amide) on the Energetic Metabolism of the Brain of Rats

International Pharmacopsychiatry August 11, 2017 V. Máthé, G. Kassay

Authors investigated the effect of LSD-25, of chlorpromazine, and of a combination of both on three parts of the brain of white rats (I: cortex and white substance extending to the subcortex; II: subcortical ganglia and medulla oblongata; III: cerebellum) upon the level of total reducing substance, glycogen, lactic, and pyruvic acid, ATP, and anorganic P. Twenty minutes after injecting 2ɣ per...

LSD experiments by the United States Army

History of Psychiatry July 7, 2017 Colin A. Ross 7 citations

Extensive LSD testing was conducted by the US Army at Edgewood Arsenal and other locations from 1955 to 1967. A number of different reports have been produced describing the health effects of this testing, including the Veterans Health Initiative Report in 2003. By and large, these reports gloss over and minimize the short and long-term side effects and complications of this testing. However,...